Jane Street
NGNE icon

Jane Street’s Neurogene NGNE Stock Holding History

Jane Street’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-24,400
Closed -$492K – 12608
2026
Q1 		$492K Buy
+24,400
New +$473K ﹤0.01% 8074
2025
Q3 		– Sell
-10,300
Closed -$154K – 11442
2025
Q2 		$154K Buy
+10,300
New +$162K ﹤0.01% 8730
2025
Q1 		– Sell
-53,000
Closed -$1.21M – 10220
2024
Q4 		$1.21M Buy
+53,000
New +$1.97M ﹤0.01% 5010

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Jane Street's NGNE Position: Q2 2026 in Review

Jane Street opened a new position in Neurogene (NGNE) in Q2 2026: 26,089 shares worth $820K. The stake represents ﹤0.01% of the portfolio and ranks #6946 among its holdings. This is a return to the name: Jane Street previously reported a position in NGNE as recently as Q4 2025.

Jane Street first reported a position in NGNE in Q1 2014 and has held it in 11 quarters since. The position peaked at $2.79M in Q1 2024. 112 funds tracked by Wall St. Rank hold NGNE as of Q2 2026.

  • Jane Street held 26,089 shares of Neurogene worth $820K as of Q2 2026.
  • Neurogene was a new Jane Street position in Q2 2026.
  • Neurogene made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #6946 holding.
  • Jane Street first reported a position in Neurogene in Q1 2014 and has held it in 11 quarters since.
  • Jane Street's Neurogene position peaked at $2.79M in Q1 2024.
  • 112 funds tracked by Wall St. Rank held Neurogene as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.